FUJIFILM Uses cutting-edge Technologies and Innovations to tackle the Covid-19 Pandemic and Build Healthier Society for Thai People

February 1, 2022 - Fujifilm (Thailand) Co. Ltd. has reinforced its position of No. 1 in Total Medical Imaging Solutions by utilizing using state-of-the-art technology and innovation that not only can it solve health issues of the Thai society, but also allowing doctors to diagnose faster and more accurately by using medical information systems and the highest performing medical devices and equipment such as digital mobile X-ray machines, ultrasound machines, endoscope systems and digital mammography machines. It also includes CT scans and MRIs of Fujifilm Healthcare Corporation, a merger with Hitachi Healthcare's imaging diagnostics business in 2021. Fujifilm has also reaffirmed its vision and commitment in its relentless innovating medical solutions through the NEVER STOP campaign.

Due to the prolonged COVID-19 pandemic, Fujifilm, as a fully integrated medical company, responds to the epidemic situation of COVID-19 with Prevention, Diagnosis and Treatment. For Prevention, Fujifilm invents and manufactures the FUJIFILM COVID-19 Ag Test, which is a rapid diagnostic test for COVID-19 antigens (Professional Use) and the Hydro Ag+, which is alcohol spray products. For Diagnostic, Fujifilm introduces the medical AI technology “REiLI” to enhance the performance of FDR Nano, a digital mobile X-ray machine that can quickly and accurately detect lung abnormalities and inflammations. This allows for more efficient patient screening. For Treatment, Fujifilm develops and manufactures Avigan, an antiviral drug that is widely used in the treatment for COVID-19 virus.